Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OTX-DP for ocular inflammation and pain after cataract surgery
NCT02034019Phase 3Completed
- Sponsor
- Ocular Therapeutix
- Start
- Feb 2014
- Primary completion
- Dec 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dexamethasone in ocular inflammation, post-operative ocular pain, sponsored by Ocular Therapeutix. Started Feb 2014; status: completed.
02
Drugs
dexamethasone
03
Conditions
ocular inflammationpost-operative ocular pain
Beyond the preview
Go deeper on NCT02034019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02034019.